Company Profiles

driven by the PitchBook Platform

Avelas Biosciences

Description

Developer of fluorescent technologies for cancer surgery. The company's technology allows real time diagnosis of metastatic nodes using proprietary platform technology of activatable cell-penetrating peptides.

2009

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$20M

Latest Deal Amount

$35M

Total Amount Raised

Description

Developer of fluorescent technologies for cancer surgery. The company's technology allows real time diagnosis of metastatic nodes using proprietary platform technology of activatable cell-penetrating peptides.

Website:

www.avelasbio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Surgical Devices

Other Industries

Diagnostic Equipment

Primary Office

11099 North Torrey Pines Road Suite 290 San Diego, CA 92037United States +1 (858) 750-4700
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Avelas Biosciences's full profile, request a free trial.

Avelas Biosciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Avelas Biosciences Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Avelas Biosciences Investors (8)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Alexandria Real Estate EquitiesReal EstateMinority000 0000000 0000
Avalon VenturesVenture CapitalMinority000 0000000 0000
Bregua CorporationOtherMinority000 0000000 0000
Ervington InvestmentsVenture CapitalMinority000 0000000 0000
PharmstandardCorporationMinority000 0000000 0000
Alexandria Real Estate Equities Real Estate
Avalon Ventures Venture Capital
Bregua Corporation Other
Ervington Investments Venture Capital
Pharmstandard Corporation

Avelas Biosciences Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Carmine StengoneChief Executive Officer, President and Board Member
Jesus Gonzalez Ph.DChief Scientific Officer
Kevin KinsellaCo-Founder
Roger Tsien Ph.DCo-Founder and and Research Collaborator
Steven Chen MDVice President, Clinical Affairs
Carmine Stengone Chief Executive Officer, President and Board Member
Jesus Gonzalez Ph.D Chief Scientific Officer
Kevin Kinsella Co-Founder
Roger Tsien Ph.D Co-Founder and and Research Collaborator
Steven Chen MD Vice President, Clinical Affairs

Avelas Biosciences Board Members (6)

NameRepresentingRoleSinceContact
Info
Andrei Petrov Ph.DSelfBoard Member000 0000
Carmine StengoneAvelas BiosciencesChief Executive Officer, President and Board Member000 0000
Claus Kremoser Ph.DSelfBoard Member000 0000
Douglas DownsSelfActing Chief Financial Officer & Board Member000 0000
Jay Lichter Ph.DAvalon VenturesManaging Director000 0000
Andrei Petrov Ph.D Board Member Self
Carmine Stengone Chief Executive Officer, President and Board Member Avelas Biosciences
Claus Kremoser Ph.D Board Member Self
Douglas Downs Acting Chief Financial Officer & Board Member Self
Jay Lichter Ph.D Managing Director Avalon Ventures
Request full access to PitchBook